PL235561A1 - - Google Patents
Info
- Publication number
- PL235561A1 PL235561A1 PL23556182A PL23556182A PL235561A1 PL 235561 A1 PL235561 A1 PL 235561A1 PL 23556182 A PL23556182 A PL 23556182A PL 23556182 A PL23556182 A PL 23556182A PL 235561 A1 PL235561 A1 PL 235561A1
- Authority
- PL
- Poland
- Prior art keywords
- carbon atoms
- independently hydrogen
- lower alkyl
- arrhythmia
- migraine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Photoreceptors In Electrophotography (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/246,459 US4332804A (en) | 1981-03-23 | 1981-03-23 | 9-[2-(3-Indolyl)ethyl]-1oxa-4,9-diazaspiro[5.5]undecan-3-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL235561A1 true PL235561A1 (enExample) | 1982-10-25 |
Family
ID=22930776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL23556182A PL235561A1 (enExample) | 1981-03-23 | 1982-03-22 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4332804A (enExample) |
| EP (1) | EP0061333B1 (enExample) |
| JP (1) | JPS57169485A (enExample) |
| KR (1) | KR830009094A (enExample) |
| AT (1) | ATE17249T1 (enExample) |
| AU (1) | AU557094B2 (enExample) |
| BR (1) | BR8201589A (enExample) |
| DE (1) | DE3268225D1 (enExample) |
| DK (1) | DK129282A (enExample) |
| ES (1) | ES510649A0 (enExample) |
| FI (1) | FI820998L (enExample) |
| IE (1) | IE52652B1 (enExample) |
| IL (1) | IL65310A (enExample) |
| NO (1) | NO820937L (enExample) |
| NZ (1) | NZ200085A (enExample) |
| PH (1) | PH17233A (enExample) |
| PL (1) | PL235561A1 (enExample) |
| PT (1) | PT74626B (enExample) |
| ZA (1) | ZA821929B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879391A (en) * | 1982-09-20 | 1989-11-07 | Pfizer Inc. | 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents |
| US4861880A (en) * | 1982-09-20 | 1989-08-29 | Pfizer Inc. | 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| US4977178A (en) * | 1982-09-20 | 1990-12-11 | Pfizer Inc. | Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents |
| GB8808433D0 (en) * | 1988-04-11 | 1988-05-11 | Merck Sharp & Dohme | Therapeutic agents |
| EP1263729B1 (en) | 2000-03-06 | 2006-12-20 | Acadia Pharmaceuticals Inc. | Azacyclic compounds for use in the treatment of serotonin related diseases |
| KR100974901B1 (ko) * | 2001-12-28 | 2010-08-10 | 아카디아 파마슈티칼스 인코포레이티드 | 모노아민 수용체 조정자로서의 스피로아자사이클릭 화합물 |
| KR20050008846A (ko) * | 2002-06-24 | 2005-01-21 | 아카디아 파마슈티칼스 인코포레이티드 | 세로토닌 수용체 제제로서의 ｎ-치환된 피페리딘 유도체 |
| US7538222B2 (en) * | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| US7253186B2 (en) * | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
| CA2512639C (en) | 2003-01-16 | 2012-10-30 | Acadia Pharmaceuticals Inc. | Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| US20050261278A1 (en) * | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US7820695B2 (en) * | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| KR101260036B1 (ko) * | 2004-09-27 | 2013-05-06 | 아카디아 파마슈티칼스 인코포레이티드 | Ｎ－(４－플루오로벤질)－ｎ－(１－메틸피페리딘－４－일)－ｎ＇－(４－(２－메틸프로필옥시)페닐메틸)카르바미드와그의 타르트레이트염 및 결정형의 합성 |
| US7790899B2 (en) * | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| ES2423485T3 (es) | 2007-03-19 | 2013-09-20 | Acadia Pharmaceuticals Inc. | Asociaciones de agonistas y antagonistas inversos 5-HT2A con antipsicóticos |
| JP2010540454A (ja) * | 2007-09-21 | 2010-12-24 | アカディア ファーマシューティカルズ，インコーポレーテッド | ピマバンセリンと他の薬剤との併用投与 |
| TWI685497B (zh) * | 2014-06-02 | 2020-02-21 | 西班牙商伊史帝夫製藥公司 | 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物 |
| EP3325444B1 (en) | 2015-07-20 | 2021-07-07 | Acadia Pharmaceuticals Inc. | Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c |
| UA123775C2 (uk) | 2015-11-16 | 2021-06-02 | Естев Фармас'Ютікалз, С.А. | Оксадіазаспіросполуки для лікування зловживання наркотичними засобами та залежності від них |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| EP3558311A1 (en) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis |
| US11135211B2 (en) | 2017-04-28 | 2021-10-05 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| WO2019046167A1 (en) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
| TWI835755B (zh) | 2017-10-17 | 2024-03-21 | 西班牙商塔拉森空調公司 | (r)-9-(2,5-二氟苯乙基)-4-乙基-2-甲基-1-氧雜-4,9-二氮雜螺[5.5]十一烷-3-酮之鹽 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3481942A (en) * | 1968-09-06 | 1969-12-02 | Smithkline Corp | Oxa-diazaspiro(4.5)decane compounds |
| US3574204A (en) * | 1969-07-03 | 1971-04-06 | Yoshitomi Pharmaceutical | Piperidine spiro compounds |
| CA952908A (en) * | 1970-02-27 | 1974-08-13 | Yoshitomi Pharmaceutical Industries | Benzodioxane derivatives |
| US3723442A (en) * | 1970-12-31 | 1973-03-27 | Yoshitomi Pharmaceutical | 3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes |
| US4255432A (en) * | 1979-09-06 | 1981-03-10 | Syntex (U.S.A.) Inc. | 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof |
-
1981
- 1981-03-23 US US06/246,459 patent/US4332804A/en not_active Expired - Fee Related
-
1982
- 1982-02-22 BR BR8201589A patent/BR8201589A/pt unknown
- 1982-03-22 NO NO820937A patent/NO820937L/no unknown
- 1982-03-22 PH PH27035A patent/PH17233A/en unknown
- 1982-03-22 EP EP82301460A patent/EP0061333B1/en not_active Expired
- 1982-03-22 IE IE648/82A patent/IE52652B1/en unknown
- 1982-03-22 DE DE8282301460T patent/DE3268225D1/de not_active Expired
- 1982-03-22 ZA ZA821929A patent/ZA821929B/xx unknown
- 1982-03-22 KR KR1019820001218A patent/KR830009094A/ko not_active Withdrawn
- 1982-03-22 ES ES510649A patent/ES510649A0/es active Granted
- 1982-03-22 PT PT74626A patent/PT74626B/pt unknown
- 1982-03-22 AT AT82301460T patent/ATE17249T1/de not_active IP Right Cessation
- 1982-03-22 DK DK129282A patent/DK129282A/da not_active Application Discontinuation
- 1982-03-22 AU AU81769/82A patent/AU557094B2/en not_active Expired - Fee Related
- 1982-03-22 PL PL23556182A patent/PL235561A1/xx unknown
- 1982-03-22 NZ NZ200085A patent/NZ200085A/en unknown
- 1982-03-22 IL IL65310A patent/IL65310A/xx unknown
- 1982-03-22 FI FI820998A patent/FI820998L/fi not_active Application Discontinuation
- 1982-03-23 JP JP57044755A patent/JPS57169485A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FI820998A7 (fi) | 1982-09-24 |
| IL65310A (en) | 1985-03-31 |
| DE3268225D1 (de) | 1986-02-13 |
| PH17233A (en) | 1984-07-03 |
| PT74626A (en) | 1982-04-01 |
| ES8306373A1 (es) | 1983-06-01 |
| EP0061333B1 (en) | 1986-01-02 |
| IL65310A0 (en) | 1982-05-31 |
| JPS57169485A (en) | 1982-10-19 |
| NO820937L (no) | 1982-09-24 |
| US4332804A (en) | 1982-06-01 |
| FI820998L (fi) | 1982-09-24 |
| IE52652B1 (en) | 1988-01-06 |
| IE820648L (en) | 1982-09-23 |
| BR8201589A (pt) | 1983-02-08 |
| PT74626B (en) | 1983-12-19 |
| ES510649A0 (es) | 1983-06-01 |
| AU8176982A (en) | 1982-09-30 |
| EP0061333A1 (en) | 1982-09-29 |
| KR830009094A (ko) | 1983-12-17 |
| NZ200085A (en) | 1985-07-12 |
| DK129282A (da) | 1982-09-24 |
| ZA821929B (en) | 1983-11-30 |
| AU557094B2 (en) | 1986-12-04 |
| ATE17249T1 (de) | 1986-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH17233A (en) | 9-/2-(3-indolyl)ethyl/-1-oxa-4,9-diazaspiro/5,5/undecan-3-ones | |
| ES486349A1 (es) | Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas | |
| AU580321B2 (en) | New tryptamine derivatives, a process for their preparation, and their use | |
| HU9301155D0 (en) | Methods for producing steroide derivatives and for their application in medical treatment | |
| IE820401L (en) | N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines | |
| MY100095A (en) | 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition. | |
| GR3004855T3 (enExample) | ||
| ZA816259B (en) | 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants | |
| AU565492B2 (en) | 4-phenyl-4-oxo-buten-2-oic acids | |
| ATE29721T1 (de) | 5-(4-vinyl- oder 4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo-(1,2-a -pyrrol-1-carbosaeure und deren derivate. | |
| ES8504181A1 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
| GR3006108T3 (enExample) | ||
| ES8307241A1 (es) | Procedimiento para la preparacion de 3-(2-(4-tetra y hexadidropiridil)-etil)indoles. | |
| DE3271277D1 (en) | Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment | |
| AU4134185A (en) | 5-oxo-3/beta (un/substituted phenyl) -2- pyrrolidine propanoic acid | |
| ZA855181B (en) | Phenylethylaminopropiophenone derivatives,a process for their preparation and medicaments containing these compounds | |
| AU561149B2 (en) | Cardiotonic 4-semicarbazide quindyolines |